Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sarifah Hanafi"'
Autor:
Xuan Shang, Zhiyu Peng, Yuhua Ye, Asan, Xinhua Zhang, Yan Chen, Baosheng Zhu, Wangwei Cai, Shaoke Chen, Ren Cai, Xiaoling Guo, Chonglin Zhang, Yuqiu Zhou, Shuodan Huang, Yanhui Liu, Biyan Chen, Shanhuo Yan, Yajun Chen, Hongmei Ding, Xiaolin Yin, Liusong Wu, Jing He, Dongai Huang, Sheng He, Tizhen Yan, Xin Fan, Yuehong Zhou, Xiaofeng Wei, Sumin Zhao, Decheng Cai, Fengyu Guo, Qianqian Zhang, Yun Li, Xuelian Zhang, Haorong Lu, Huajie Huang, Junfu Guo, Fei Zhu, Yuan Yuan, Li Zhang, Na Liu, Zhiming Li, Hui Jiang, Qiang Zhang, Yijia Zhang, Wan Khairunnisa Wan Juhari, Sarifah Hanafi, Wanjun Zhou, Fu Xiong, Huanming Yang, Jian Wang, Bin Alwi Zilfalil, Ming Qi, Yaping Yang, Ye Yin, Mao Mao, Xiangmin Xu
Publikováno v:
EBioMedicine, Vol 23, Iss C, Pp 150-159 (2017)
Hemoglobinopathies are among the most common autosomal-recessive disorders worldwide. A comprehensive next-generation sequencing (NGS) test would greatly facilitate screening and diagnosis of these disorders. An NGS panel targeting the coding regions
Externí odkaz:
https://doaj.org/article/ddb85bcb4ac24f0987fd7226623d7a62
Autor:
Sarifah Hanafi, Wan Zaidah Abdullah, Bin Alwi Zilfalil, Rosline Hassan, R. Diana, Rosnah Bahar, Nurul Fatihah Azman, Muhammad Farid Johan
Publikováno v:
Annals of Hematology. 99:729-735
HbE/Beta thalassemia (HbE/β-thalassemia) is one of the common genetic disorders in South East Asia. It is heterogeneous in its clinical presentation and molecular defects. There are genetic modifiers which have been reported to influence the disease
Autor:
Bin Alwi Zilfalil, Tilak R. Shrestha, Sarifah Hanafi, Matrika Bhattarai, Rosline Hassan, Wardah Yusof, Raju Lama
Publikováno v:
Hematology/Oncology and Stem Cell Therapy.
Background Beta-thalassemia is a genetic disorder that is inherited in an autosomal recessive pattern. This genetic disease leads to a defective beta-globin hemoglobin chain causing partial or complete beta-globin chain synthesis loss. Beta-thalassem
Autor:
Zhiming Li, Bin Alwi Zilfalil, Huanming Yang, Fu Xiong, Qiang Zhang, Li Zhang, Jian Wang, Wanjun Zhou, Hongmei Ding, Asan, Yun Li, Dongai Huang, Fengyu Guo, Shaoke Chen, Yaping Yang, Wangwei Cai, Xiaolin Yin, Fei Zhu, Xuelian Zhang, Shuodan Huang, Sarifah Hanafi, Sumin Zhao, Liusong Wu, Na Liu, Xin Fan, Tizhen Yan, Jing He, Xiaoling Guo, Yuhua Ye, Ming Qi, Decheng Cai, Yuehong Zhou, Ye Yin, Xiaofeng Wei, Zhiyu Peng, Ren Cai, Yajun Chen, Xuan Shang, Xinhua Zhang, Yanhui Liu, Hui Jiang, Junfu Guo, Yan Chen, Baosheng Zhu, Mao Mao, Yuqiu Zhou, Biyan Chen, Huajie Huang, Yijia Zhang, Haorong Lu, Qianqian Zhang, Shanhuo Yan, Xiangmin Xu, Sheng He, Wan Khairunnisa Wan Juhari, Chonglin Zhang, Yuan Yuan
Publikováno v:
EBioMedicine
EBioMedicine, Vol 23, Iss C, Pp 150-159 (2017)
EBioMedicine, Vol 23, Iss C, Pp 150-159 (2017)
Hemoglobinopathies are among the most common autosomal-recessive disorders worldwide. A comprehensive next-generation sequencing (NGS) test would greatly facilitate screening and diagnosis of these disorders. An NGS panel targeting the coding regions